IPP Bureau
Dr Reddy’s appoints Amit Golash as Global Head-Customer Service & Logistics
By IPP Bureau - April 22, 2022
He has extensive leadership experience across supply chain and has worked at companies such as Unilever, Flipkart, Colgate-Palmolive & Mondelez
First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal
By IPP Bureau - April 22, 2022
The first use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter
KBI Biopharma opens mammalian manufacturing facility in North Carolina
By IPP Bureau - April 22, 2022
Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
Evusheld significantly protected against symptomatic Covid-19 for at least six months
By IPP Bureau - April 21, 2022
Pre-exposure prevention trial reduced risk of symptomatic Covid-19, with no severe disease or Covid-19-related deaths in the Evusheld group
Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results
By IPP Bureau - April 21, 2022
Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both
Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing
By IPP Bureau - April 21, 2022
Support for biologics manufacturability and Industry 4.0 initiatives
Merck announces Joseph Romanelli will lead Merck Human Health International
By IPP Bureau - April 21, 2022
In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S
Lupin engages Flutura to accelerate digitial drive using AI
By IPP Bureau - April 21, 2022
Flutura to deploy Cerebra Digital Twin & Pharmacologist Workbench, a self-service AI platform to accelerate impact on Pharmaceutical outcomes
Saraq Hepatitis C kit receives CDSCO nod
By IPP Bureau - April 21, 2022
The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth
Dr. Reddy's launch Posaconazole delayed-release tablets in the US
By IPP Bureau - April 21, 2022
The tablets are available in 100 mg strength in bottle count sizes of 60
Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses
By IPP Bureau - April 21, 2022
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
CK Birla Hospital performs highest number of VABB surgeries in a year
By IPP Bureau - April 21, 2022
Vacuum-Assisted Breast Biopsy (VABB) is an innovative and more effective alternative to the traditional method where benign lumps are removed surgically, leaving scars and causing distress
Veeva Vault CTMS launched at Bristol Myers Squibb
By IPP Bureau - April 21, 2022
Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed
ZEISS announces USFDA clearance of the Quatera 700
By IPP Bureau - April 21, 2022
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise
Purigen launches ionic cells to pure DNA kit
By IPP Bureau - April 21, 2022
New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques